Elwakeel, A.; Sari, A.N.; Dhanjal, J.K.; Meidinna, H.N.; Sundar, D.; Kaul, S.C.; Wadhwa, R.
Mutant p53L194F Harboring Luminal-A Breast Cancer Cells Are Refractory to Apoptosis and Cell Cycle Arrest in Response to MortaparibPlus, a Multimodal Small Molecule Inhibitor. Cancers 2021, 13, 3043.
https://doi.org/10.3390/cancers13123043
AMA Style
Elwakeel A, Sari AN, Dhanjal JK, Meidinna HN, Sundar D, Kaul SC, Wadhwa R.
Mutant p53L194F Harboring Luminal-A Breast Cancer Cells Are Refractory to Apoptosis and Cell Cycle Arrest in Response to MortaparibPlus, a Multimodal Small Molecule Inhibitor. Cancers. 2021; 13(12):3043.
https://doi.org/10.3390/cancers13123043
Chicago/Turabian Style
Elwakeel, Ahmed, Anissa Nofita Sari, Jaspreet Kaur Dhanjal, Hazna Noor Meidinna, Durai Sundar, Sunil C. Kaul, and Renu Wadhwa.
2021. "Mutant p53L194F Harboring Luminal-A Breast Cancer Cells Are Refractory to Apoptosis and Cell Cycle Arrest in Response to MortaparibPlus, a Multimodal Small Molecule Inhibitor" Cancers 13, no. 12: 3043.
https://doi.org/10.3390/cancers13123043
APA Style
Elwakeel, A., Sari, A. N., Dhanjal, J. K., Meidinna, H. N., Sundar, D., Kaul, S. C., & Wadhwa, R.
(2021). Mutant p53L194F Harboring Luminal-A Breast Cancer Cells Are Refractory to Apoptosis and Cell Cycle Arrest in Response to MortaparibPlus, a Multimodal Small Molecule Inhibitor. Cancers, 13(12), 3043.
https://doi.org/10.3390/cancers13123043